These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Molecular and clinical spectrum of four pedigrees of TRAPS in Greece: results from a national referral center. Nezos A; Argyropoulou OD; Klinaki E; Marketos N; Karagianni P; Eliopoulos E; Vlachoyiannopoulos P; Maritsi DN; Tzioufas AG Rheumatology (Oxford); 2020 Jun; 59(6):1241-1246. PubMed ID: 31562507 [TBL] [Abstract][Full Text] [Related]
25. [A family of tumor necrosis factor receptor-associated periodic syndrome]. Li S; Ou RQ; Zhang BH; Zhang YN; Wang HY; Tan WP Zhonghua Er Ke Za Zhi; 2019 Jun; 57(6):477-482. PubMed ID: 31216807 [No Abstract] [Full Text] [Related]
26. The TNF receptor-associated periodic syndrome (TRAPS): emerging concepts of an autoinflammatory disorder. Hull KM; Drewe E; Aksentijevich I; Singh HK; Wong K; McDermott EM; Dean J; Powell RJ; Kastner DL Medicine (Baltimore); 2002 Sep; 81(5):349-68. PubMed ID: 12352631 [TBL] [Abstract][Full Text] [Related]
27. A signalome screening approach in the autoinflammatory disease TNF receptor associated periodic syndrome (TRAPS) highlights the anti-inflammatory properties of drugs for repurposing. Todd I; Negm OH; Reps J; Radford P; Figueredo G; McDermott EM; Drewe E; Powell RJ; Bainbridge S; Hamed M; Crouch S; Garibaldi J; St-Gallay S; Fairclough LC; Tighe PJ Pharmacol Res; 2017 Nov; 125(Pt B):188-200. PubMed ID: 28860008 [TBL] [Abstract][Full Text] [Related]
28. Novel mutation identified in severe early-onset tumor necrosis factor receptor-associated periodic syndrome: a case report. Radhakrishna SM; Grimm A; Broderick L BMC Pediatr; 2017 Apr; 17(1):108. PubMed ID: 28427379 [TBL] [Abstract][Full Text] [Related]
29. TRAPS mutations in Akagi T; Hiramatsu-Asano S; Ikeda K; Hirano H; Tsuji S; Yahagi A; Iseki M; Matsuyama M; Mak TW; Nakano K; Ishihara K; Morita Y; Mukai T Front Immunol; 2022; 13():926175. PubMed ID: 35936010 [TBL] [Abstract][Full Text] [Related]
31. Molecular analysis of the MVK and TNFRSF1A genes in patients with a clinical presentation typical of the hyperimmunoglobulinemia D with periodic fever syndrome: a low-penetrance TNFRSF1A variant in a heterozygous MVK carrier possibly influences the phenotype of hyperimmunoglobulinemia D with periodic fever syndrome or vice versa. Stojanov S; Lohse P; Lohse P; Hoffmann F; Renner ED; Zellerer S; Kéry A; Shin YS; Haas D; Hoffmann GF; Belohradsky BH Arthritis Rheum; 2004 Jun; 50(6):1951-8. PubMed ID: 15188372 [TBL] [Abstract][Full Text] [Related]
33. Tumor necrosis factor receptor-associated periodic fever syndrome in a 58-year-old man: caution not to discount TRAPS as a diagnosis in older patients. Sinožić D; Toplak N; Milotić I J Clin Rheumatol; 2011 Sep; 17(6):325-8. PubMed ID: 21869706 [TBL] [Abstract][Full Text] [Related]
34. Role of tumour necrosis factor (TNF)-α and TNFRSF1A R92Q mutation in the pathogenesis of TNF receptor-associated periodic syndrome and multiple sclerosis. Caminero A; Comabella M; Montalban X Clin Exp Immunol; 2011 Dec; 166(3):338-45. PubMed ID: 22059991 [TBL] [Abstract][Full Text] [Related]
35. The tumor-necrosis-factor receptor-associated periodic syndrome: new mutations in TNFRSF1A, ancestral origins, genotype-phenotype studies, and evidence for further genetic heterogeneity of periodic fevers. Aksentijevich I; Galon J; Soares M; Mansfield E; Hull K; Oh HH; Goldbach-Mansky R; Dean J; Athreya B; Reginato AJ; Henrickson M; Pons-Estel B; O'Shea JJ; Kastner DL Am J Hum Genet; 2001 Aug; 69(2):301-14. PubMed ID: 11443543 [TBL] [Abstract][Full Text] [Related]
37. Clinical and functional characterisation of a novel TNFRSF1A c.605T>A/V173D cleavage site mutation associated with tumour necrosis factor receptor-associated periodic fever syndrome (TRAPS), cardiovascular complications and excellent response to etanercept treatment. Stojanov S; Dejaco C; Lohse P; Huss K; Duftner C; Belohradsky BH; Herold M; Schirmer M Ann Rheum Dis; 2008 Sep; 67(9):1292-8. PubMed ID: 18180277 [TBL] [Abstract][Full Text] [Related]
38. Tumour necrosis factor receptor-associated periodic syndrome (TRAPS): state of the art and future perspectives. Cantarini L; Lucherini OM; Muscari I; Frediani B; Galeazzi M; Brizi MG; Simonini G; Cimaz R Autoimmun Rev; 2012 Nov; 12(1):38-43. PubMed ID: 22884554 [TBL] [Abstract][Full Text] [Related]
39. Typical and severe tumor necrosis factor receptor-associated periodic syndrome in the absence of mutations in the TNFRSF1A gene: a case series. Cantarini L; Lucherini OM; Cimaz R; Rigante D; Baldari CT; Laghi Pasini F; Galeazzi M Rheumatol Int; 2012 Dec; 32(12):4015-8. PubMed ID: 20473499 [TBL] [Abstract][Full Text] [Related]